Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Beninger

Showing results (1-10 of 99) with videos related to

Pageof 10
Sort By:
Clinical Therapeutics|April 4, 2017
Opportunities for Collaboration at the Interface of Pharmacovigilance and ManufacturingPaul Beninger
Clinical Therapeutics|December 28, 2025
LYNKUET® (elinzanetant)Paul Beninger
Clinical Therapeutics|July 13, 2023
FezolinetantPaul Beninger
Clinical Therapeutics|April 23, 2025
Mycobacterium tuberculosis: A Resurgent Scourge Writing Another Chapter in Its HistoryPaul Beninger
Clinical Therapeutics|February 15, 2025
Crenessity (crinecerfont)Paul Beninger
Vaccine|April 15, 2022
Need for a contingency dimension when planning vaccine development in a pandemic environmentPaul Beninger
Clinical Therapeutics|September 24, 2024
Xolremdi-MavorixaforPaul Beninger
Clinical Therapeutics|July 19, 2025
Treatment of Older Patients with Acute Pain: A Complex MilieuPaul Beninger
Clinical Therapeutics|March 18, 2026
ZYCUBO (copper histidinate)Paul Beninger
Clinical Therapeutics|April 16, 2026
Erratum to "New Drug Capsule BLUJEPA (gepotidacin)" [Clin Ther. 2026;48:291-293]Paul Beninger
Pageof 10

Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
Clinical Therapeutics|April 4, 2017
Opportunities for Collaboration at the Interface of Pharmacovigilance and ManufacturingPaul Beninger
Clinical Therapeutics|December 28, 2025
LYNKUET® (elinzanetant)Paul Beninger
Clinical Therapeutics|July 13, 2023
FezolinetantPaul Beninger
Clinical Therapeutics|April 23, 2025
Mycobacterium tuberculosis: A Resurgent Scourge Writing Another Chapter in Its HistoryPaul Beninger
Clinical Therapeutics|February 15, 2025
Crenessity (crinecerfont)Paul Beninger
Vaccine|April 15, 2022
Need for a contingency dimension when planning vaccine development in a pandemic environmentPaul Beninger
Clinical Therapeutics|September 24, 2024
Xolremdi-MavorixaforPaul Beninger
Clinical Therapeutics|July 19, 2025
Treatment of Older Patients with Acute Pain: A Complex MilieuPaul Beninger
Clinical Therapeutics|March 18, 2026
ZYCUBO (copper histidinate)Paul Beninger
Clinical Therapeutics|April 16, 2026
Erratum to "New Drug Capsule BLUJEPA (gepotidacin)" [Clin Ther. 2026;48:291-293]Paul Beninger
Pageof 10